» Articles » PMID: 10643895

Early Regional Cerebral Glucose Hypometabolism in Transgenic Mice Overexpressing the V717F Beta-amyloid Precursor Protein

Overview
Journal Neurosci Lett
Specialty Neurology
Date 2000 Jan 22
PMID 10643895
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

In the present study, we examined whether the relative levels of regional brain [14C]2-deoxyglucose (2-DG) uptake are altered in a transgenic mouse model of Alzheimer's disease which overexpresses a mutated form of the human beta-amyloid precursor protein (mutation V717F). We show that the relative levels of 2-DG uptake are significantly reduced in the septum, thalamus, dentate gyrus and parietal cortex of 3-month-old transgenic mice as compared with wild-type littermates. In 10-month-old transgenic mice, these alterations also extend to the CA3 hippocampal region, the cingulate, retrosplenial, occipital and temporal cortices, suggesting an age-dependent decrease in the regional 2-DG uptake. These results suggest that expression of a mutated APP gene induces an early regional cerebral hypometabolism independently of amyloid deposition per se.

Citing Articles

Involvement of Glucosamine 6 Phosphate Isomerase 2 (GNPDA2) Overproduction in β-Amyloid- and Tau P301L-Driven Pathomechanisms.

Lachen-Montes M, Cartas-Cejudo P, Cortes A, Anaya-Cubero E, Peral E, Ausin K Biomolecules. 2024; 14(4).

PMID: 38672412 PMC: 11048700. DOI: 10.3390/biom14040394.


Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer's disease.

Armstrong P, Gungor H, Anongjanya P, Tweedy C, Parkin E, Johnston J Neuropsychopharmacology. 2024; 49(10):1559-1568.

PMID: 38521860 PMC: 11319650. DOI: 10.1038/s41386-024-01852-z.


Hypometabolism, Alzheimer's Disease, and Possible Therapeutic Targets: An Overview.

Raut S, Bhalerao A, Powers M, Gonzalez M, Mancuso S, Cucullo L Cells. 2023; 12(16).

PMID: 37626828 PMC: 10453773. DOI: 10.3390/cells12162019.


Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.

Nehra G, Bauer B, Hartz A Pharmacol Ther. 2022; 234:108119.

PMID: 35108575 PMC: 9107516. DOI: 10.1016/j.pharmthera.2022.108119.


Early detection of cryptic memory and glucose uptake deficits in pre-pathological APP mice.

Beglopoulos V, Tulloch J, Roe A, Daumas S, Ferrington L, Watson R Nat Commun. 2016; 7:11761.

PMID: 27249364 PMC: 4895343. DOI: 10.1038/ncomms11761.